SINE (selective inhibitor of nuclear export) – translational science in a new class of anti-cancer agents
Open Access
- 4 October 2014
- journal article
- editorial
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 7 (1) , 1-3
Abstract
Regulation of protein trafficking between the nucleus and cytoplasm represents a novel control point for antineoplastic intervention. Several proteins involved with cellular growth and survival depend on precise and timely positioning within the cell to fulfill their functions, and the nuclear membrane defines one of the most important compartmental barriers. Chromosome Region Maintenance 1, or exportin-1 (CRM1/XPO1), is involved with the export of more than 200 nuclear proteins, and has intriguingly been shown to have an increased expression in several tumor cell types. Selinexor (KPT-330) is a first-in-class selective inhibitor of nuclear export (SINE) to be developed for clinical use. Preclinical data has demonstrated antineoplastic activity of SINE compounds in many human solid and hematologic malignancies. The clinical development of Selinexor provides an excellent model for translational research.Keywords
This publication has 19 references indexed in Scilit:
- Clinical translation of nuclear export inhibitors in cancerSeminars in Cancer Biology, 2014
- Use of Statins and the Risk of Death in Patients With Prostate CancerJournal of Clinical Oncology, 2014
- Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276Leukemia, 2013
- Prognostic impact and targeting of CRM1 in acute myeloid leukemiaBlood, 2013
- Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphomaExperimental Hematology, 2013
- Inhibition of CRM1-Mediated Nucleocytoplasmic Transport: Triggering Human Melanoma Cell Apoptosis by Perturbing Multiple Cellular PathwaysJournal of Investigative Dermatology, 2012
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaBlood, 2012
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSISNeurosurgery, 2009
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationInternational Journal of Cancer, 2009
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancerCancer, 2008